How Ph.D. was paid
$13.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|
| David Campbell, Ph.D.President and Chief Executive Officer | $680,000 | — | — | $12,459,031 | $367,200 | — | $13,506,231 |
| Thomas DiRaimondo, Ph.D.Chief Scientific Officer | $478,000 | — | — | $3,691,565 | $175,904 | — | $4,345,469 |
| Janeen DoyleChief Corporate and Business Development Officer | $309,963 | $75,000 | $995,280 | $3,124,983 | $114,066 | $50,000 | $4,669,292 |
| Zachariah McIver, D.O., Ph.D.Former Chief Medical Officer | $475,000 | — | — | $3,999,195 | $165,300 | — | $4,639,495 |
| Byron Robinson, Ph.D., J.D.Former Chief Strategy Officer | $362,728 | — | — | $4,306,826 | — | $394,081 | $5,063,635 |
What changed and why
- $13.5MDavid Campbell received total compensation of $13,506,231 in fiscal 2025, an increase from $8,974,873 in fiscal 2024.
- 90%The Board and Compensation Committee determined a corporate goal achievement level of 90% for 2025.
- 87%NEO annual bonuses were paid out between 87% and 92% of target based on corporate and individual goals.
- $75,000Janeen Doyle joined the company in May 2025 with a sign-on bonus of $75,000.
- 97.9%Approximately 97.9% of stockholder votes cast supported the say-on-pay proposal at the 2025 annual meeting.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.